New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
10:03 EDTDELL, ROK, NVDA, DNDN, HNZ, CLF, CTL, FTI, END, TRIP, TWC, MDT, PGR, ITRI, H, ETR, DAL, LMTOn the Fly: Analyst Downgrade Summary
Today’s noteworthy downgrades include: Dell (DELL) downgraded to Hold from Buy at Brean Capital... Delta Air Lines (DAL) downgraded to Underweight from Equal Weight at Evercore... Entergy (ETR) downgraded to Sell from Neutral at UBS... Hyatt Hotels (H) downgraded to Market Perform from Outperform at FBR Capital... Itron (ITRI) downgraded to Hold from Buy at Brean Capital... Medtronic (MDT) downgraded to Neutral from Buy at Lazard Capital... Progressive (PGR) downgraded to Equal Weight from Overweight at Barclays... Time Warner Cable (TWC) downgraded to Sector Perform from Outperform at RBC Capital... TripAdvisor (TRIP) downgraded to Equal Weight from Overweight at Morgan Stanley... Endeavour (END) downgraded to Sell from Buy at Wunderlich... FMC Technologies (FTI) downgraded to Hold from Buy at Societe Generale... CenturyLink (CTL) downgraded to Neutral from Buy at Citigroup... Cliffs Natural (CLF) downgraded to Fair Value from Buy at CRT Capital... Heinz (HNZ) downgraded to Hold from Buy at Deutsche Bank... Dendreon (DNDN) downgraded to Sell from Hold at Maxim... NVIDIA (NVDA) downgraded to Hold from Buy at Needham... Rockwell Automation (ROK) downgraded to Market Perform from Outperform at Bernstein... Lockheed Martin (LMT) downgraded to Neutral from Outperform at Cowen.
News For DELL;DAL;ETR;H;ITRI;PGR;MDT;TWC;TRIP;END;FTI;CTL;CLF;HNZ;DNDN;NVDA;ROK;LMT From The Last 14 Days
Check below for free stories on DELL;DAL;ETR;H;ITRI;PGR;MDT;TWC;TRIP;END;FTI;CTL;CLF;HNZ;DNDN;NVDA;ROK;LMT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
September 17, 2014
06:09 EDTMDTIntegra LifeSciences to acquire Medtronic instrumentation lines for $60M
Integra LifeSciences (IART) and Medtronic (MDT) announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for approximately $60M in cash. Integra expects the transaction to close in Q4. Integra will acquire a portfolio of approximately 4,000 MicroFrance and Xomed manual ENT and laparoscopic surgical instruments, as well as the St. Aubin le Monial, France manufacturing facility. Sales from the products being acquired totaled approximately $30M, two-thirds of which were generated outside the U.S. Integra expects to record approximately $27M-$30M in revenue and approximately 10c of adjusted EPS in calendar 2015 from this acquisition. The earnings accretion should rise after the first year once certain sales transitions are complete. The company expects the acquisition to contribute less than $5M in revenue and be neutral to earnings in Q4. The transition and integration is expected to be completed by 2H15.
September 16, 2014
17:22 EDTLMTUnited Launch Services awarded $938.37M government contract modification
United Launch Services, a 50-50 joint venture owned by Lockheed Martin (LMT) and Boeing (BA), has been awarded a $938.37M modification to previously awarded FA8811-13-C-0003 cost-plus-incentive-fee contract for FY15 EELV launch capability for the Delta IV and Atlas V families of launch vehicles. This contract provides for mission assurance, program management, systems engineering, integration of the space vehicle with the launch vehicle, launch site and range operations, and launch infrastructure maintenance and sustainment. Work will be performed at Littleton, Colorado; Vandenberg Air Force Base, California; and Cape Canaveral Air Station, Florida, with an expected completion date of Sept. 30, 2015.
16:36 EDTROKRockwell Automation initiated with a Buy at Stifel
Subscribe for More Information
13:50 EDTTWCComcast says will reveal capital plan at close of Time Warner Cable deal
Subscribe for More Information
13:40 EDTTWCComcast says still expects Time Warner Cable deal to close in 2015
13:38 EDTTWCComcast says 'everything on track' with Time Warner Cable deal
Subscribe for More Information
11:57 EDTLMTPentagon to most likely approve Musk's Falcon rockets, WSJ says
Subscribe for More Information
11:51 EDTMDTOECD looks to close tax loopholes with new proposals
Subscribe for More Information
11:42 EDTTWCTime Warner Cable sees Comcast deal closing early FY15
Subscribe for More Information
09:59 EDTFTIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:04 EDTLMTLockheed Martin's meteorological satellite accepted for operations by USSTRATCOM
Subscribe for More Information
08:46 EDTFTIDril-Quip price target lowered to $120 from $137 at FBR Capital
Subscribe for More Information
08:08 EDTFTIFMC Technologies downgraded to Market Perform from Outperform at FBR Capital
FBR Capital downgraded FMC Technologies to Market Perform citing expectations for a reduction in the volume of subsea well starts. FBR lowered its price target for shares to $58 from $68.
08:07 EDTMDTMedtronic drug-coated baloon shows strong clinical, economic benefit
Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics, or TCT, conference, the latest clinical and economic data on the IN.PACT Admiral drug-coated balloon, or DCB, from Medtronic augments an already robust body of evidence that continues to drive a reconsideration of the standard of care for peripheral artery disease, or PAD, in leg arteries above the knee. The IN.PACT Admiral DCB remains an investigational medical device in the United States. No drug-coated balloon has yet received approval from the FDA. The new data come from the real-world IN.PACT Global study, the largest and most rigorous post-market evaluation of its kind for any peripheral artery intervention, and from an ongoing economic outcomes analysis of the U.S. phase of the landmark IN.PACT SFA trial. Together, the results show that the IN.PACT Admiral DCB is not only clinically superior, but also cost-effective for the treatment of atherosclerotic lesions in the superficial femoral artery, or SFA, or proximal popliteal artery, or PPA, at 12 months compared to standard percutaneous transluminal angioplasty, or PTA.
07:31 EDTMDTEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
07:29 EDTETRBofA/Merrill to hold a conference
2014 Power and Gas Leaders Conference to be held in Boston on September 16-17.
07:27 EDTTWCBofA/Merrill to hold a conference
Subscribe for More Information
07:15 EDTLMTPratt expects upcoming F-35 agreements to reduce espenses, Reuters says
Subscribe for More Information
06:34 EDTLMTBoeing, Lockheed ally with Amazon CEO on rocket engine, Reuters says
Subscribe for More Information
06:29 EDTLMTPratt & Whitney close to engine supply deal with Pentagon, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use